Journal of Surgical Research
Volume 144, Issue 1 , Pages 1-7 , January 2008

Opposing Regulation of the Tight Junction Protein Claudin-2 by Interferon-γ and Interleukin-4

Presented at the 1st Annual Academic Surgical Congress, San Diego, CA, February 8, 2006.

Received 8 March 2006

References 

  1. Schneeberger EE, Lynch RD. The tight junction: A multifactorial complex. Am J Physiol Cell Physiol. 2004;286:C1213
  2. Furuse M, Fujita K, Hiragi T, et al. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998;141:1539
  3. Poritz LS, Lynch CJ, Tilberg AF, et al. Decreased expression of occludin in the intestine of patients with inflammatory bowel disease. FASEB J. 1997;11:A310
  4. Koltun WA, Tillberg AF, Page MJ, et al. Bowel permeability is improved in Crohn’s disease after ileocolectomy. Dis Colon Rectum. 1998;41:687
  5. Schmitz H, Barmeyer C, Fromm M, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 1999;116:301
  6. Gassler N, Rohr C, Schneider A, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiolol Gastrointest Liver Physiol. 2001;281:G216
  7. Prasad S, Mingrino R, Kaukinen K, et al. Inflammatory processes have differential effects on claudins 2, 3, and 4 in colonic epithelial cells. Lab Invest. 2005;85:1139
  8. Zeissig S, Burgel N, Gunzel D, et al. Changes in expression and distribution of claudin-2, -5, and -8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut. 2007;56:61
  9. Poritz LS, Garver K, Tilberg AF, et al. Tumor necrosis factor α disrupts tight junction assembly. J Surg Res. 2004;116:14
  10. Youakim A, Ahdieh M. Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol. 1999;276:G1279
  11. Di Leo V, Yang PC, Berin MC, et al. Factors regulating the effect of IL- 4 on intestinal epithelial barrier function. Int Arch Allergy Immunol. 2002;129:219
  12. Colgan SP, Resnick MB, Parkos CA, et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol. 1994;153:2122–2129
  13. Yoo J, Nochols A, Song JC, et al. Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: Role of novel PKC isozymes. Am J Physiol Gatrointest Liver Physiol. 2003;284:G703
  14. Han X, Fink MP, Delude RL. Proinflammatory cytokines cause NO-dependent and independent changes in expression and localization of tight junction proteins in intestinal epithelial cell. Shock. 1994;19:229
  15. Colegio OR, Van Itallie CM, McCrea HJ, et al. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol. 2002;283:C142
  16. Furuse M, Furuse K, Sasaki H, et al. Conversion of zonae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Bio. 2001;153:263–272
  17. Van Itallie C, Rahner C, Anderson J. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest. 2001;107:1319
  18. Noguchi M, Hiwathashi N, Liu Z, et al. Enhanced interferon-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn’s disease. J Gastroenterol. 1995;30(Suppl 8):S52
  19. Fuss IJ, Neurath M, Boirivant M, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease (Crohn’s disease LP cells manifest increased secretion of IFNγ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5). J Immunol. 1996;157:1261
  20. Inoue S, Matsumoto T, Iida M, et al. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: Correlation with disease activity. Am J Gastroenterol. 1999;94:2441
  21. Poritz LS, Garver KI, Thompson J, et al. Induction of claudin- 1 in IEC-6 cells by IL-4. J Sur Res. 2004;121:311
  22. Van Itallie C, Fanning A, Anderson J. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol. 2003;28:F1078
  23. Amasheh S, Meiri N, Gitter A, et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci. 2002;115:4969
  24. Adams R, Planchon S, Roche K. IFNγ modulation of epithelial barrier function, time course, reversibility, and site of cytokine binding. J Immunol. 1993;150:2356
  25. Madara JL, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest. 1989;83:724
  26. Willemsen LEM, Hoetjes JP, Van Deventer SJH, et al. Abrogation of IFN-γ mediated epithelial barrier disruption by serine protease inhibition. Clin Exp Immunol. 2005;142:275
  27. Bamias G, Nyce MR, De La Rue SA, et al. New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med. 2005;143:895
  28. Schultz M, Scholmerich J, Rath HC. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases. Dig Dis. 2003;21:105
  29. Macfarlane GT, Furrie E, Macfarlane S. Bacterial milieu and mucosal bacteria in ulcerative colitis. Novartis Found Symp. 2004;263:57
  30. Mahida YR, Rolfe VE. Host bacterial interactions in inflammatory bowel disease. Clin Sci. 2004;107:331
  31. Linskens RK, Huijsdens XW, Savelkoul PH, et al. The bacterial flora in inflammatory bowel disease: Current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol. 2001;234(Suppl):S29
  32. Caradonna L, Amati L, Magrone T, et al. Enteric bacteria, lipopolysaccharides, and related cytokines in inflammatory bowel disease: Biological and clinical significance. J Endotoxin Res. 2000;6:205
  33. Nelms K, Keegan AS, Zamorano J, et al. The IL-4 receptor: Signaling mechanisms and biologic functions. Ann Rev Immunol. 1999;17:701
  34. Dickensheets HL, Venkataraman C, Schindler U, et al. Interferons inhibit activation of STAT6 by interleukin-4 in human monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci USA. 1999;96:10800
  35. Kobayashi J, Inai T, Morita K, et al. Reciprocal regulation of permeability through a cultured keratinocyte sheet by IFN-γ and IL-4. Cytokine. 2004;28:186
  36. Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal permeability in patients with Crohn’s disease and their relatives: A possible etiologic factor. Ann Intern Med. 1986;105:883
  37. Niesser M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995;101:428
  38. Desreumaux P, Brandt E, Gambiez L, et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn’s disease. Gastroenterology. 1997;113:118

PII: S0022-4804(07)00193-X

doi: 10.1016/j.jss.2007.03.059

Journal of Surgical Research
Volume 144, Issue 1 , Pages 1-7 , January 2008

Article Tools

* Image Usage & Resolution